A study comparing the action of atracurium from vecuronium in general anesthesia

A comparative study of action of atracurium vs action of vecuronium in general anesthesia - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077526

Enrollment

Registered

2024-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: atracurium: Eligible participants will be randomly allocated to atracurium 0.5 mg/kg group for 1 year Control Intervention1: rocuronium: Eligible participants will be randomly allocated

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status classification I or II Patients who provide informed consent for participation.

Exclusion criteria

Exclusion criteria: patient over 90 kg. Pregnant or breastfeeding women. a history of renal, hepatic or neuromuscular disease, asthma, hypersensitivity to anaesthetic agents. ASA 3 or above

Design outcomes

Primary

Measure	Time frame
To explore the dose-response relationship between atracurium and vecuronium during general anaesthesiaTimepoint: Every 3 min for 15 min then every 15 min till recovery	—

Secondary

Measure	Time frame
To identify any potential predictors of optimal dose selection of atricurium and rocuronium based on individual patient factors & surgical requirementsTimepoint: Every 3 min for 15 min then every 15 min till recovery	—

Countries

India

Contacts

Public ContactDr Shivam jaiswal

Varun Arjun Medical College and Rohilkhand Hospital

mirbashir96@gmail.com9682536855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026